Cart
sales@molnova.com
5-TAMRA
CAS No. 91809-66-4
5-TAMRA( 5-Carboxytetramethylrhodamine )
Catalog No. M24965 CAS No. 91809-66-4
5-TAMRA (5-Carboxytetramethylrhodamine) yields bright, pH-insensitive orange-red fluorescence (approximate excitation/emission maxima ~546/579) with good photostability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 90 | In Stock |
|
| 100MG | 127 | In Stock |
|
| 200MG | 184 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-TAMRA
-
NoteResearch use only, not for human use.
-
Brief Description5-TAMRA (5-Carboxytetramethylrhodamine) yields bright, pH-insensitive orange-red fluorescence (approximate excitation/emission maxima ~546/579) with good photostability.
-
Description5-TAMRA (5-Carboxytetramethylrhodamine) yields bright, pH-insensitive orange-red fluorescence (approximate excitation/emission maxima ~546/579) with good photostability.
-
In Vitro——
-
In Vivo——
-
Synonyms5-Carboxytetramethylrhodamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91809-66-4
-
Formula Weight430.45
-
Molecular FormulaC25H22N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:60 mg/mL (139.39 mM)
-
SMILESCN(C1=CC2=C(C(C3=CC=C(C([O-])=O)C=C3C(O)=O)=C4C=C/C(C=C4O2)=[N+](C)/C)C=C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Alclofenac
Alclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
-
4-Methylmorpholine N...
N-Methylmorpholine N-oxide (more correctly 4-methylmorpholine 4-oxide), NMO or NMMO is an organic compound.
-
Ibrolipim
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
